PATENT CLAIM ANALYSIS

Application Number: 16213354
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["435", "006140"]

Abstract:
Provided herein are methods and compositions for isolating and detecting nucleic acids from platelet-enriched plasma.

Claim (Index 1):
A method of detecting a target nucleic acid comprising:\n a) obtaining a blood sample from a subject; b) separating platelet-enriched plasma (PEP) from other blood components; c) purifying nucleic acids from the PEP; and d) detecting the target nucleic acid, wherein detection is carried out by PCR, next generation sequencing (NGS), or hybridization, and wherein the target nucleic acid is associated with cancer.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 98.0
- Lexical Diversity: 1.06667
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13577335', '13581795', '15274788', '12901467', '14357475']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5218655321811232
- 35 USC 102 Novelty (BERT): 0.4921709119978452
- Combined Prediction Score: 0.5188960701627954
- Mean Citation Score: 203.70101800000003
- Max Citation Score: 209.45274
- Similarity Product: 149.6794529139483

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test